Mots-clés
Organismes > OEDT
OEDTSynonyme(s)Observatoire européen des drogues et des toxicomanies European Monitoring Centre for Drugs and Drug Addiction |
Documents disponibles dans cette catégorie (472)
Article : Périodique
'Spice' is a herbal mixture sold on the internet, samples of which have been found to contain new synthetic drugs which produce effects similar to cannabis. The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)'s early warning sys[...]Article : Périodique
In April 2023, the Taliban banned poppy cultivation and the trade of all narcotics. This caused a 95% reduction in opium production. Usually, that would be good news. But there is a substantial worry: synthetic opioids might fill the void left b[...]Article : Périodique
D. HEDRICH ; E. KALAMARA ; O. SFETCU ; A. PHARRIS ; A. NOOR ; L. WIESSING ; V. HOPE ; M. J. VAN DE LAAR |In most European Union (EU)/European Economic Area (EEA) countries, between 2010 and 2012, reports of new human immunodeficiency virus (HIV) diagnoses among people who inject drugs have been stable or declining. HIV outbreaks in Greece and Roman[...]Article : Périodique
V. CATALANI ; D. ARILLOTTA ; J. M. CORKERY ; A. GUIRGUIS ; A. VENTO ; F. SCHIFANO |COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. Th[...]Rapport
OEDT = EMCDDA ; A. PIRONA ; L. MONTANARI ; I. GIRAUDON ; J. MATIAS ; K. OIEN ; L. VANDAM ; T. SURMONT ; B. GUARITA ; F. MATHIS ; J. MOUNTENEY ; K. NATONIEWSKA ; S. SLEIMAN ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Ad hoc publication | 2021Since early 2020, the COVID-19 pandemic has had a dramatic impact on the way we live, with European countries having to introduce unprecedented measures to protect public health. As with all areas of life, drug consumption, related harms and dru[...]Rapport
OEDT = EMCDDA ; J. FOUNTAIN ; G. BURKHART ; L. MONTANARI | Lisbon : OEDT / EMCDDA | Technical reports | 2017This report provides an overview of the various types of brief interventions (BIs) currently used in European countries in the field of substance use, particularly illicit drugs. Targeted at policymakers and practitioners alike, it covers more t[...]Rapport
This report provides a summary of the key findings from the assessment of progress of the EU Member States, Norway and Turkey towards the implementation of the revised drug supply indicators, as developed by the EMCDDA in line with the Council c[...]Rapport
ENGLISH : This report presents the results of a European project to improve the comparability of general population surveys on drug use prevalence. The project was commissioned by the EMCDDA and carried out by O+S Amsterdam, in close cooperati[...]Article : Périodique
Changing the severity of statutory penalties for cannabis use offences does not appear to have a consistent impact on cannabis use by young adults, and new policy responses to the proliferation of new psychoactive substances within European coun[...]Rapport
OEDT = EMCDDA ; D. HEDRICH ; K. PALCZAK ; K. KEPA ; N. SINGLETON | Lisbon : OEDT / EMCDDA | Manuals | 2021This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment[...]Article : Périodique
May 2014 saw the launch of the European drug report (EDR), the European Monitoring Centre for Drugs and Drug Addiction's (EMCDDAs) annual review of the European drug market, incorporating trend analysis, topic overviews, statistical data and ind[...]Article : Périodique
ENGLISH: AIMS: To quantify changes in (i) potency (concentration of Delta9-tetrahydrocannabinol; %THC), (ii) price (euros/g of cannabis) and (iii) value (mg THC/euro) of cannabis resin and herbal cannabis in Europe. DESIGN: Repeated cross-sect[...]Article : Périodique
G. BURKHART, Personne interviewée ; M. PORTNER-HELFER, Intervieweur |En matière de stratégie de prévention, il est souvent question de campagnes d'information à large échelle ou de mesures ciblées destinées à modifier les comportements des individus par rapport à leur consommation. En agissant davantage sur l'env[...]Rapport
Commission des communautés européennes = Commission of the European communities ; OEDT = EMCDDA | 1993FRANÇAIS : Ce document constitue un recueil de la majorité des textes officiels de la communauté européenne depuis environ vingt ans. Il s'agit d'une des premières publications de l'Observatoire Européen des Drogues dont les objectifs et l'org[...]Article : Périodique
T. SEYLER ; I. GIRAUDON ; A. NOOR ; J. MOUNTENEY ; P. GRIFFITHS |This paper addresses the question of whether Europe is facing an opioid epidemic and utilises data from the European monitoring system on opioid use, harms and availability, to help assess the situation. Data sources covering the last decade on [...]Rapport
OEDT = EMCDDA ; M. EVANS-BROWN ; A. GALLEGOS ; R. SEDEFOV ; A. ALMEIDA ; R. CHRISTIE ; P. DUQUE ; A. GALLEGOS ; R. JORGE ; J. DE MORAIS | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2020This publication presents the data and findings of the risk assessment on N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5-nitro-1H-benzimidazole-1- ethanamine (isotonitazene), carried out by the extended Scientific Committee of the EMCDDA on [...]Rapport
The aim of this paper is to focus on the harmful interaction between psychoactive drug use and sexual activity. It is acknowledged that in some individuals co-occurrence of drug consumption and sexual activity causes no apparent harm, but this g[...]Article : Périodique
P. GRIFFITHS ; D. LOPEZ ; R. SEDEFOV ; A. GALLEGOS ; B. HUGHES ; A. NOOR ; L. ROYUELA |AIM OF THE STUDY: To review the information available on the use of khat (Catha edulis) in the EU, and to assess the future use of this drug and related substances. MATERIAL AND METHODS: Khat is not controlled by international law and it has not[...]Article : Périodique
Background: Registries for drug deaths may include different persons and provide different characteristics of the deceased. The aim of this study was to establish whether a database of drug-induced deaths (Cause of Death Registry (CDR) using the[...]NouveautéRapport
FRANÇAIS : Cette synthèse de la littérature compare les différents modes de consommation de drogues, la conduite sous influence et les accidents de la route. Elle décrit également les procédures de dépistage des drogues, les législations exist[...]Brochure
In this brochure, the EMCDDA's Scientific Director takes us on a journey through 25 years of annual reporting on the drugs problem in Europe. The journey begins with the first report describing the drug situation in 1995 and leads us, over key m[...]Rapport
The open sale of cannabis products in Europe has raised concerns among policymakers, both with regard to the legal status of these products and their potential for harm. The products are marketed for their low THC (tetrahydrocannabinol) content,[...]Article : Périodique
The European Monitoring Centre for Drugs and Drug Addiction, EMCDDA, publishes statistics for overdose deaths giving a European mean number, and ranking nations in a national 'league table' for overdose deaths. The interpretation of differing na[...]Chapitre
OEDT = EMCDDA | 2012FRANÇAIS : L'usage de drogue est associé directement et indirectement à une grande diversité de conséquences négatives sur la santé et la vie sociale. Ces problèmes concernent dans une mesure disproportionnée les usagers d'opiacés de longue dur[...]Rapport
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en-PINACA. The report is intended for policymakers and decision-makers in the inst[...]Rapport
OEDT = EMCDDA ; A. M. DINES ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (MDPV), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Congrès
Reitox Academy for Baltic countries: Monitoring trends in and responses to drug-related infectious diseases among people who inject drugs (21-22 November 2013; Tallinn) ; OEDT = EMCDDA, Organisateur de réunion ; European Centre for Disease Prevention and Control, Organisateur de réunion | Lisbon : OEDT / EMCDDA | 2013This meeting, a regional Reitox Academy held in Tallinn (21-22 November 2013) contributed to maximising synergies at national level between institutions and experts in the fields of drug monitoring and infectious disease surveillance in four cou[...]Rapport
Internet and Drugs expert meeting (7 and 8 June 2016; Brussels) | Brussels : European Commission, Directorate-General Migration and Home Affairs | 2016In June 2016, in the framework of the EU Internet Forum, DG HOME organised an expert meeting on internet and drugs. The main points addressed were: analysis of the problem we are confronted with and finding a common definition for it; looking cl[...]Congrès
3rd Meeting on detecting and responding to outbreaks of HIV among people who inject drugs (18 November 2013; Bucharest) ; Roundtable on the HIV situation among people who inject drugs in Romania (19 November 2013; Bucharest) ; OEDT = EMCDDA, Organisateur de réunion ; European Centre for Disease Prevention and Control, Organisateur de réunion | Lisbon : OEDT / EMCDDA | 2013This expert meeting held in Bucharest (18-19 November 2013) provided an important opportunity for sharing knowledge and best practice among experts from six countries in the south and south-east of the European region (Cyprus, Greece, Hungary, M[...]Article : Périodique
FRANÇAIS : Cette livraison résume certaines idées actuelles sur l'utilisation des indicateurs de la prévalence et de l'incidence pour aider à l'élaboration de la politique de l'UE sur les drogues. Il suggère d'autres sources pour ceux qui souh[...]Rapport
This publication is the first in a series dedicated to prevalent illicit synthetic stimulant drugs, also known as amphetamine-type stimulants (ATS). The ATS category is made up of two groups of substances. This study focuses on the supply and us[...]Rapport
This report provides a comprehensive overview of the methamphetamine market in the European Union. It assesses the current threat situation regarding current trends in production, trafficking and distribution.Rapport
OEDT = EMCDDA ; D. M. WOOD ; P. I. DARGAN | Lisbon : OEDT / EMCDDA | Risk assessments, ISSN 1725-4493 | 2014This report presents the data and findings of the risk assessment on the new psychoactive substance, 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine), that was conducted by the Scientific Committee of the EMCDDA. Concerns over t[...]Rapport
This publication presents the data and findings of the risk assessment on 2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide (methoxyacetylfentanyl), carried out by the extended Scientific Committee of the EMCDDA on 21 March 2018. O[...]Rapport
Unusually high numbers of migrants have moved to Europe in recent years, with about 1.2 million people applying for asylum in the European Union in each of the years 2015 and 2016. Fears have been expressed that this group's health status and po[...]Livre
C. GODFREY ; L. WIESSING ; R. HARTNOLL, Éditeur scientifique | Lisbon : OEDT / EMCDDA | Monographs, ISSN 1606-1691 | 2001FRANÇAIS : La modélisation est un moyen technique de simplifier des processus complexes. Ceci est accompli grâce à l'informatique et l'utilisation de formules mathématiques décrivant de manière quantitative les éléments constituant le processu[...]Rapport
S. ARNAUD ; J. P. GERVASONI ; F. DUBOIS-ARBER | Lausanne : Unisanté - Centre universitaire de médecine générale et santé publique | Raisons de santé, ISSN 1660-7104 | 2010Le Monitorage national des dépendances (ou Addiction Monitoring in Switzerland - AMIS) répond à un appel d’offre de l’Office de la santé publique (OFSP). Il a pour but d’identifier les besoins en matière d’indicateurs de surveillance dans le dom[...]Rapport
FRANÇAIS : Ce rapport explore la manière dont, à travers des enquêtes sur des populations ciblées, sont recueillies des données sur l'usage de drogues dans l'espace récréatif public (pubs, bars, clubs, scènes musicales) et privé en Europe. Il r[...]Article : Périodique
D. RHUMORBARBE ; M. MORELATO ; L. STAEHLI ; C. ROUX ; D. O. JAQUET-CHIFFELLE ; Q. ROSSY ; P. ESSEIVA |Background: The rapid emergence of new psychoactive substances (NPS) is a challenge for public health authorities and law enforcement. The phenomenon is strengthened since the increase of the Internet usage. Not only used to trade NPS, the Web i[...]Rapport
This technical report focuses on an elimination barometer for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among people who inject drugs (PWID). The barometer is being developed by the EMCDDA together w[...]Rapport
L. LANIEL ; C. CARPENTIER ; C. COSTA STORTI ; D. LOPEZ ; C. MARTEL ; L. ROYUELA ; R. SEDEFOV ; J. WRIGHT ; F. ZOBEL ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008Growing cocaine use in several EU countries, and increased seizures of cocaine on air, sea and land routes, have become subjects of increasing concern to policymakers. This datasheet provides a short review of key issues relating to how cocaine [...]Rapport
L. LANIEL ; D. LOPEZ ; J. WRIGHT ; C. CARPENTIER ; D. MANSFIELD ; L. ROYUELA ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Technical Datasheets, ISSN 1831-2314 | 2008ENGLISH : In recent years, anxiety in Europe has increased about the impact of record opium harvests in Afghanistan, and a decrease in heroin retail prices. This datasheet provides a condensed review of the key issues about how heroin manufact[...]Rapport
Drug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological indicator wi[...]Rapport
OEDT = EMCDDA ; I. GIRAUDON ; M. BUSTER ; A. ESPELT ; J. MATIAS ; J. VICENTE | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2015This paper examines the overall number of lives lost due to drug use. All-cause mortality among problem drug users is investigated by means of cohort studies, which link data from death registries to drug treatment records. Building on earlier w[...]Article : Périodique
H. LOPEZ-PELAYO ; J. VICENTE ; A. GALLEGOS ; A. McAULEY ; Y. BUYUK ; M. WHITE ; I. GIRAUDON |Background-Aims: New psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the drug conventions of the United Nations. In the last 10 years, numerous NPS have been identified in Europe but there is no co[...]Rapport
This Selected issue focuses on mortality among drug users due to all causes, of which drug-induced deaths (overdoses) is only a component, albeit the one most well-documented. The publication begins with an introduction to mortality cohort studi[...]Rapport
This publication presents the data and findings of the risk assessment on MT-45 (1-cyclohexyl-4-(1, 2-diphenylethyl)piperazine), carried out by the extended Scientific Committee of the EMCDDA on 16 September 2014. The main part of the publicatio[...]Rapport
FRANÇAIS : Cette « Question particulière » de l'OEDT concernant la recherche nationale en matière de drogue en Europe décrit brièvement le cadre dans lequel la recherche en matière de drogue est menée dans les pays européens. Elle examine plus[...]Rapport
R. SIMON ; L. KRAUS ; R. BAUERNFEIND ; B. BIELEMAN ; J. M. COSTES ; F. MARIANI ; B. OLSSON ; L. WIESSING | Munich : IFT | 1996A work group was installed in order to support the development of methods for the estimation of prevalence of problematic drug use at national level. Participants of this group were experts, which had been involved in national estimation procedu[...]Rapport
OEDT = EMCDDA ; V. AUWÄRTER ; J. DE MORAIS ; A. GALLEGOS ; M. EVANS-BROWN ; R. CHRISTIE ; R. JORGE ; R. SEDEFOV | Lisbon : OEDT / EMCDDA | Rapid communication | 2021This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System. The aims of this report are to strengthen situational awareness of new benzodiazepines in E[...]